Partek Incorporated has reached a milestone by having its software cited in over three thousand peer-reviewed scientific publications including prestigious publications such as New England Journal of Medicine, Cell, and Nature.
On average that is about two citations per business day in the last five years on topics including drug research, human genetics and disease relationships, causes, diagnosis, and treatments. Samples of scientific papers citing the use of Partek software are listed on the Partek website.
When asked the reason so many researchers have used Partek software in their publications, Donald Meyer, COO for Partek, pointed to their long history in the genomics field as well as the ease of use of their software. “Partek software has been used in the Life Sciences for more than 15 years. We are proud that we have been able to assist scientists in their studies of disease and treatments.”
“All of us at Partek get a great deal of satisfaction knowing that the software we create is being used by scientists to advance the health and well-being of people worldwide,” said Tom Downey, CEO of Partek.